What You Will Learn:

  • 1. The Reality Of Decentralized Trials

    What’s actually working, where breakdowns are occurring, and how oversight, accountability, and site readiness are being challenged in hybrid and decentralized models.

  • 2. AI in Clinical Trials: Risk, Responsibility, & Adoption

    How AI is being used in documentation and operations, where bias and validation risks exist, and what sponsors expect from sites adopting emerging technologies.

  • 3. Why Clinical Trial Delays Start at the Investigator Level

    The operational, regulatory, and leadership gaps that lead to delays plus how physician engagement, oversight, and decision-making directly impact trial success.

Course curriculum

    1. Day 1: The Decentralized Trial Reality What’s Working & What’s Quietly Failing March 23, 2026

    1. Day 2: Is AI Actually helping our workflows at the Site Level for Principal Investigators?

    1. Day 3: Why Clinical Trial Delays Often Start at the Investigator Level

Behind the Hype: Clinical Trials 2026 is a 3-Day executive briefing designed for physicians and clinical research professionals seeking to understand what is actually working in today's trial landscape.

  • $47.00
  • 3 lessons
  • 3 hours of video content
  • Session 1: The Realities of Decentralized Trials
  • Session2: The risks and expectations surrounding AI adoptions
  • Session 3: Why Delays often originate at the investigator level

What Sponsors Expect in 2026

Where Physicians Impact Trial Success

Alisha Moore

CEO

Alisha Moore CEO of Clinical Science Research Solutions and the Founder I.A.M. Research & Wellness Foundation works to expand clinical research access in underserved communities by helping physicians launch research programs and build clinical trial infrastructure in rural regions. She supports physicians and research sites by building sustainable clinical research programs and integrating modern research technology into real-world clinical environments. On Day 1 she will be discussing: The Decentralized Trial Reality What's Working and What's Quietly Failing

Huzaifa Hussain

CEO/Founder

Huzaifa is the Founder & CEO of Emerge Research Institute and Co-Founder of Pulse, leading initiatives focused on high-quality, ethical, and efficient clinical trials. His work centers on building research infrastructure through strong physician leadership, streamlined site operations, and patient-centered recruitment particularly in underserved communities. In this session, Huzaifa explores AI in Clinical Trials: Innovation… or Liability? covering AI-assisted documentation, risks of algorithmic bias, validation expectations, sponsor-driven adoption, and the critical question of accountability when AI-generated outputs go wrong.

Damien Hall

Director of CRA Academy

Senior Clinical Operations Leader with 20 years of operational excellence across multiple therapies, phases, organizations and clinical research landscapes across APAC, North America, and the EU/Europe. Proven track record of success in optimizing clinical trial operations, managing complex clinical trials and achieving deliverables. Elite at problem-solving, team-building and innovate leadership through adaptive “resourcing,” and strategic improvements, resulting in the continuous development of high-functioning teams and sought after consultation within SMO, ARO, CRO, and Sponsors. On Day 3, he discusses why clinical trial delays often start at the Principal Investigator level.

Behind the Hype: Clinical Trials 2026

What's Really Working Today!

Want to learn more? Enroll Today!